RNA interference against discoidin domain receptor 2 ameliorates alcoholic liver disease in rats

Zheng Luo1, Huimin Liu, Xiaomeng Sun

  • 1Department of Geriatric Gastroenterology, Qilu Hospital of Shandong University, Jinan, Shandong, China.

Plos One
|February 15, 2013
PubMed

Insights

Discoidin domain receptor 2 (DDR2) plays a key role in early alcoholic liver disease. Inhibiting DDR2 reduced liver injury and cell proliferation, suggesting it as a potential therapeutic target.

Area of Science:

  • Hepatology
  • Molecular Biology
  • Fibrosis Research

Background:

  • Fibrotic diseases are often linked to discoidin domain receptor 2 (DDR2).
  • The specific role of DDR2 in early alcoholic liver disease (ALD) remains unclear.
  • Understanding DDR2's function is crucial for developing targeted therapies for ALD.

Purpose of the Study:

  • To investigate the pathogenic role of DDR2 in early alcoholic liver disease.
  • To assess the therapeutic potential of inhibiting DDR2 in ALD.

Main Methods:

  • Construction of plasmid vectors for short-hairpin RNA (shRNA) against DDR2.
  • Utilized immortalized rat hepatic stellate cell line (HSC-T6) and a rat model of ALD.
  • Employed MTT assays, RT-PCR, western blot, immunohistochemistry, and electron microscopy.

Main Results:

  • Alcohol exposure upregulated DDR2, correlating with matrix metalloproteinase 2, TGF-β1 signaling, TIMP-1, collagen deposition, and ECM remodeling.
  • Inhibition of DDR2 significantly reduced HSC-T6 cell proliferation.
  • Silencing DDR2 decreased liver injury in rats with 10-week-induced ALD.

Conclusions:

  • DDR2 is implicated in the pathogenesis of early-stage alcoholic liver disease.
  • Targeting DDR2 through silencing may offer a preventative strategy for early ALD.